Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: The txt2heart Colombia randomised controlled trial protocol

Introduction Anti-platelet therapy, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, beta-blockers and statins are cost-effective in patients with atherosclerotic cardiovascular diseases (ASCVD) for reducing the risk of ASCVD events. Unfortunately, there is abundant evidenc...

Full description

Autores:

Bermon A.
Uribe-Rodríguez A.F.
Pérez-Rivero P.F.
Prieto-Merino D.
Cáceres Rivera, Diana Isabel
Guio E.
Atkins L.
Horne R.
Murray E.
Serrano DÍaz N.C.
Free C.
Perel P.
Casas J.P.

Tipo de recurso:

Article of journal

Fecha de publicación:

2023

Institución:

Universidad Cooperativa de Colombia

Repositorio:

Repositorio UCC

Idioma:

OAI Identifier:

oai:repository.ucc.edu.co:20.500.12494/51042

Acceso en línea:

https://doi.org/10.1136/bmjopen-2018-028017
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076268991&doi=10.1136%2fbmjopen-2018-028017&partnerID=40&md5=8e9eba1ee1ff2bc9a075b0d8436b4d64
https://hdl.handle.net/20.500.12494/51042

Palabra clave:

11 OXOTHROMBOXANE B2
ADULT
ANGIOTENSIN RECEPTOR ANTAGONIST
ARTICLE
ATORVASTATIN
BEHAVIOR CHANGE
BETA ADRENERGIC RECEPTOR BLOCKING AGENT
BLOOD
CARDIOVASCULAR AGENT
CONTROLLED STUDY
CORONARY ARTERY ATHEROSCLEROSIS
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR
FLUINDOSTATIN
HEART RATE
HUMAN
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL
MEDICATION COMPLIANCE
PATIENT COMPLIANCE
PRAVASTATIN
PROGRAM EFFICACY
RANDOMIZED CONTROLLED TRIAL
ROSUVASTATIN
SECONDARY PREVENTION
SELF REPORT
SIMVASTATIN
SINGLE BLIND PROCEDURE
SYSTOLIC BLOOD PRESSURE
TEXT MESSAGING

Rights

openAccess

License

http://purl.org/coar/access_right/c_abf2